search

Active clinical trials for "Macular Edema"

Results 781-790 of 850

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections...

Age Related Macular DegenerationDiabetic Macular Edema1 more

In patients treated for exudative age-related macular degeneration (AMD), diabetes, retinal venous occlusion (OVR), or other conditions causing macular edema, treatments with anti-angiogenic intravitreal injections (IVT) are widely used both for their anti-angiogenic action. Patients often have injections for many years, sometimes monthly or every 2 months. The discontinuation of treatment with repeated injections of anti-angiogenic agents, linked to the COVID-19 coronavirus pandemic will potentially impact the visual acuity, the ophthalmological state and the quality of life of the patients concerned, therefore it is relevant to analyze the consequences the breakdown of usual care in this population.

Completed3 enrollment criteria

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

AMD - Age-Related Macular DegenerationDiabetic Macular Edema

Primary objective: To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula in AMD (Age-related Macular Degeneration) patients. Secondary objectives: To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula in DME (Diabetic Macular Edema) patients. To evaluate patient experience when self-operating the Notal-OCT V2.5.

Completed6 enrollment criteria

Ocular Manifestations in Rheumatic Diseases

UveitisConjunctivitis16 more

This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.

Completed5 enrollment criteria

A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

Macular Edema

This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.

Completed3 enrollment criteria

Glycemic Control and Diabetic Macular Edema

Diabetic Macular Edema

Does diabetic patients' glycemic control affect their response to laser and/or intravitreal injection therapy in terms of visual and anatomical outcomes.

Completed4 enrollment criteria

Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal...

Diabetic Macular Edema

The purpose of this study is to identify Diabetic Macular Edema (DME) characteristics in eyes that show different response to treatment with anti-VEGF (vascular endothelial growth factor) injections of Lucentis.

Completed14 enrollment criteria

Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients

Diabetic RetinopathyDiabetic Macular Edema

The aim of this study is to investigate the conjunctival bacterial flora and antibiotic resistance patterns following serial intravitreal injections of anti-VEGF in diabetic patients, using a povidone-iodine preparation without preinjection or postinjection topical antibiotics.

Unknown status9 enrollment criteria

A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic...

Diabetic Macular Edema

Establish the efficacy of initial high frequency loading of intravitreal pegaptanib bi-weekly during the initial treatment period when the VEGF levels are the greatest and then gradually extending the administration frequency to monthly as homeostasis ensues for the treatment of DME, as measured by best-corrected visual acuity.

Available17 enrollment criteria

Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX

Macular Edema

Patients who were diagnosed as postoperative CME and administrated with intravitreal OZURDEX injection were reviewed. Outcome will include best-corrected visual acuity (BCVA), intraocular pressure (IOP) and central macular thickness (CMT). Recurrent CME and corresponding treatments were recorded.

Completed5 enrollment criteria

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Macular Edema

This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).

Completed2 enrollment criteria
1...787980...85

Need Help? Contact our team!


We'll reach out to this number within 24 hrs